President & Chief Commercial Officer
United States of America
Blischak joined the Nexeon team with over 20 years of experience in the medical device field and 16 years of experience in neuromodulation serving in senior commercial operations and executive roles for ImThera Medical and St. Jude Medical. He joined from ImThera Medical, Inc., a developer of an implantable neurostimulation system for sleep apnea, where he served for four years as Senior Vice President of Sales and Marketing. Prior to that, Mr. Blischak spent twelve years in the St. Jude Medical Neuromodulation Division (SJM), where he led the commercialization and launch of two major deep brain stimulation (DBS) product families consisting of over 20 products in more than 15 countries, including the patient recruitment efforts for two pivotal Investigational Device Exemption (IDE) studies for Parkinson's disease and essential tremor and two IDE feasibility studies for major depressive disorder.
Investigational Device Exemption (IDE) studies for Parkinson's disease and essential tremor and two IDE feasibility studies for major depressive disorder. neuromodulation, medical device field